SFV HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Workers on Monday will hold a protest at Providence Tarzana Medical Center, which recently terminated approximately half its housekeeping staff.
West Hills Hospital & Medical Center on Tuesday opened its Advanced Wound Care Center to treat patients with hard-to-heal wounds.
Simulations Plus reported results that beat Wall Street expectations.
Amgen Inc. on Monday announced it has entered into a collaboration and licensing agreement with German pharmaceutical company Immatics Biotechnologies to develop next-generation cancer treatments.
Two San Fernando Valley hospitals face fines from the California Department of Public Health over violations that present “immediate jeopardy” to patients or have already resulted in injury or death.
Cynvenio Biosystems Inc. in Westlake Village has released its second-generation ClearID Breast Cancer blood test, the company announced Monday.
Antelope Valley Hospital has named a new chief executive, following the district board’s Dec. 23 decision to oust prior administrative leader John Rossfeld.
Valencia biotech MannKind Corp. on Tuesday announced that it has received a $1 million milestone payment from Receptor Life Sciences Inc. of Seattle for completing initial formulation studies.
Antelope Valley Hospital will face reduced Medicare payments based on a health care quality score, according to the Antelope Valley Press.
A local nonprofit dental clinic for low-income children has received a significant donation from Henry Schein Inc., the world’s largest distributor of dentistry supplies.
The Federal Trade Commission gave its approval for the $25 billion acquisition of St. Jude Medical Inc. by Abbott Laboratories by requiring that Abbott sell off two medical device businesses.
Glendale health management company Apollo Medical Holdings Inc. has signed a definitive agreement to merge with Network Medical Management Inc. of Alhambra, the companies announced Thursday.
Second Sight Medical Products Inc. on Thursday announced that Britain’s National Health Service will subsidize implantations of the Argus II Retinal Prosthesis System in 10 patients suffering from blindness.
ImmunoCellular Therapeutics Ltd. on Wednesday announced that the board of directors has appointed Dr. Anthony Gringeri as its new chief executive, following the resignation of former chief executive Andrew Gengos.
Medical device maker Medtronic Inc. has been fined $17.2 million by Chinese regulators for alleged price fixing in regard to its diabetes and cardiovascular devices.